Nantahala Capital Management’s Gyre Therapeutics GYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,520	Closed	-$32.7K	–	136
2023 Q3	$32.7K	Hold	4,520	–	–	﹤0.01%	130
2023 Q2	$23.8K	Sell	4,520 -6,175	-58%	-$22.1K	﹤0.01%	122
2023 Q1	$33.2K	Sell	10,695 -47,712	-82%	-$181K	﹤0.01%	121
2022 Q4	$231K	Sell	58,407 -282,224	-83%	-$1.15M	0.02%	108
2022 Q3	$1.29M	Sell	340,631 -26,823	-7%	-$341K	0.13%	85
2022 Q2	$4.91M	Buy	367,454 +44,682	+14%	+$297K	0.43%	62
2022 Q1	$1.6M	Sell	322,772 -45,449	-12%	-$225K	0.11%	94
2021 Q4	$2.52M	Buy	368,221 +43,926	+14%	+$751K	0.16%	97
2021 Q3	$10M	Sell	324,295 -13,220	-4%	-$435K	0.59%	63
2021 Q2	$11M	Sell	337,515 -3,996	-1%	-$137K	0.6%	67
2021 Q1	$12.9M	Buy	341,511 +92,800	+37%	+$4.24M	0.73%	54
2020 Q4	$11.8M	Buy	248,711 +5,811	+2%	+$252K	0.61%	59
2020 Q3	$7.83M	Hold	242,900	–	–	0.52%	71
2020 Q2	$10.7M	Buy	242,900 +50,000	+26%	+$2.35M	0.69%	59
2020 Q1	$6.32M	Buy	192,900 +50,000	+35%	+$2.3M	0.52%	61
2019 Q4	$7.3M	Buy	142,900 +1,188	+0.8%	+$49.8K	0.48%	57
2019 Q3	$5.22M	Buy	141,712 +2,666	+2%	+$144K	0.38%	69
2019 Q2	$7.69M	Buy	139,046 +11,280	+9%	+$705K	0.45%	58
2019 Q1	$7.77M	Buy	127,766 +13,734	+12%	+$883K	0.51%	56
2018 Q4	$6.75M	Buy	+114,032	New	+$8.41M	0.5%	69